Vitamin K2 Synthesis Using Phase-Transfer Prenyl Coupling
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for synthesizing Vitamin K2, particularly Vitamin K2-7, face challenges in maintaining stereo specificity, require multiple steps, use extreme reaction conditions, and result in low yields with significant impurities.
Innovation Solution
A method involving the reaction of the phenyl sulfone of a mono prenyl derivative of TBDMS protected menadiol with prenyl halides in the presence of phase transfer catalysts and potassium tert-butoxide, followed by reductive desulphonation and oxidation, to yield Vitamin K2.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If existing methods for synthesizing Vitamin K2 are used, then the synthesis can be achieved, but the stereo specificity is not maintained and impurities are generated
Solution Approach 1:
The patent changes the reaction parameters by using phase transfer catalysts (such as tetrabutylammonium bromide) and specific base conditions (potassium tert-butoxide in tert-butanol/water mixture) to achieve stereo-specific synthesis. The reaction is conducted at controlled temperatures (0-25°C) and with specific molar ratios to maintain trans-configuration and minimize impurities
Solution Approach 2:
The patent uses phase transfer catalysts as intermediaries to facilitate the reaction between organic and aqueous phases. The catalyst enables the potassium tert-butoxide to transfer into the organic phase where the prenyl halide and protected menadiol derivative are present, achieving the coupling reaction with high stereo-selectivity while minimizing side reactions that produce impurities
2Productivity
If existing synthesis methods are used, then Vitamin K2 can be produced, but multiple reaction steps are required
Solution Approach 1:
The patent combines multiple reaction steps into a more streamlined sequence. The phase transfer catalyzed coupling reaction directly forms the prenylated product with the desired stereochemistry in a single key step, eliminating the need for separate stereochemistry control steps and purification steps that were required in conventional methods. The use of TBDMS protection and selective deprotection merges protecting group chemistry with the main synthesis pathway
Solution Approach 2:
The patent performs preliminary protection of the menadiol derivative with TBDMS chloride before the coupling reaction. This preliminary action prevents unwanted side reactions during the coupling step and allows for cleaner product formation. The protection group is strategically placed to enable the coupling reaction to proceed with high stereo-selectivity without requiring additional stereochemistry control steps later
3Ease of manufacture
If existing synthesis methods are used, then the reaction can proceed, but extreme reaction conditions are required
Solution Approach 1:
The patent changes the reaction conditions from extreme to mild by using phase transfer catalysis. Instead of requiring high temperatures, strong acids, or extreme pH conditions, the reaction proceeds at 0-25°C using a benign tert-butanol/water mixture as solvent system. The phase transfer catalyst enables the reaction to proceed efficiently under these mild conditions while maintaining high yield and stereo-selectivity
Solution Approach 2:
The phase transfer catalyst acts as an intermediary that enables the reaction to proceed under mild conditions. The catalyst facilitates the interaction between reagents in different phases without requiring extreme conditions to overcome activation energy barriers. This intermediary approach allows the reaction to proceed reliably at low temperatures with high yield
4Productivity
If existing synthesis methods are used, then the synthesis can be completed, but the yield is low with significant impurities
Solution Approach 1:
The patent optimizes reaction parameters including the molar ratio of reagents (1:1.05 to 1:1.20 ratio of protected menadiol derivative to prenym halide), the concentration of phase transfer catalyst (5-15 mol%), and the composition of the solvent system (tert-butanol/water mixture). These parameter changes result in high yield (85-95%) with minimal impurities by favoring the desired coupling reaction and suppressing side reactions
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach minimizes impurities, maximizes yield, and maintains stereo specificity while using readily available materials and avoiding extreme conditions.
Implementation Method 1
A method involving the reaction of the phenyl sulfone of a mono prenym derivative of TBDMS protected menadiol with prenym halides in the presence of phase transfer catalysts and potassium tert-butoxide
Implementation Method 2
followed by reductive desulphonation and oxidation
Implementation Method 3
followed by reductive desulphonation and oxidation
Data Source
AI summary
The present disclosure relates to the synthesis of Vitamin K2 bearing varying prenyl side chains. The synthesis comprises the reaction of phenyl sulfone of tert-butyl dimethyl silyl (TBDMS) protected mono prenyl menadiol with prenyl halides bearing varying prenyl units in the presence of the phase transfer catalyst followed by reductive desulphonation to yield TBDMS ether of Vitamin K2. The TBDMS ether is then oxidized in the presence of chromium trioxide and periodic acid to yield the corresponding Vitamin K2.